Pharm
Nortriptyline
search
Nortriptyline
, Aventyl, Pamelor
See Also
Tricyclic Antidepressant
Amitriptyline
Antidepressant
SNRI
Tricyclic Antidepressant Overdose
Indications
Migraine Headache Prophylaxis
Fibromyalgia
Chronic Pain
(esp. neuropathic pain)
Major Depression
(historical use, replaced by
SSRI
and SNRI
Antidepressant
s)
Panic Disorder
with
Agoraphobia
Obsessive Compulsive Disorder
Tobacco Cessation
Insomnia
Good nighttime sleep without daytime grogginess
Inexpensive (generic)
Precautions
See
Tricyclic Antidepressant
s
See
Tricyclic Antidepressant Overdose
Serious cardiotoxicity in overdosage
Dosing
Major Depression
Adults
Start 25 mg orally three to four times daily (or combined dosing once to twice daily)
Maximum: 150 mg/day
Elderly or Teens
Start 30 to 50 mg orally once daily or in divided dosing
Maximum: 150 mg/day
Dosing
Migraine Headache Prophylaxis
,
Fibromyalgia
,
Chronic Pain
Start at 25 mg orally at bedtime for 3 days
Next: 50 mg orally at bedtime for 3 days
Therapeutic Target Dose: 75 mg orally at bedtime
Max: 150 mg/day
Pharmacokinetics
Not effective at low dose
Plasma levels correlate better with efficacy than with other
Tricyclic Antidepressant
s
Therapeutic serum level: 50 to 150 ng/ml
Serum Half Life: 18 to 45 hours
Narrow therapeutic window when used
Always obtain a serum level after 75 mg for 7 days
Adverse effects
See
Tricyclic Antidepressant
s
Tricyclic Antidepressant Overdose
Much less adverse effects than the first generation tertiary amines (e.g.
Amitriptyline
)
Moderate
Anticholinergic
adverse effects (e.g. Sedation)
Resources
Nortriptyline (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1f5e650-e83f-4343-a025-fc90f645a796
References
(2023) Med Lett Drugs Ther 62(1592): 25-32
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 38-9
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here